SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Docebo Inc. (DCBO) trades at a trailing P/E of 12.4, forward P/E of 10.4. Trailing earnings yield is 8.04%, forward earnings yield 9.63%. PEG 0.24 (Peter Lynch undervalued ≤1.0). Graham Number is $8.74.
Criteria proven by this page:
- VALUE (97/100, Pass) — P/E is below market average (12.4); PEG ≤ 1.0 — Peter Lynch undervalued (0.24); analyst target implies upside (+103.7%); earnings yield beats bond yields (8.04%).
- Forward P/E 10.4 (down from trailing 12.4) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.24 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 8.04% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 9.63% as earnings recover.
- Analyst consensus target $31.86 (+103.7% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 85/100 with 6/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
97/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — DCBO
Valuation Multiples
P/E (TTM)12.4
Forward P/E10.4
PEG Ratio0.24
Forward PEG0.65
P/B Ratio6.37
P/S Ratio1.94
EV/EBITDA14.2
Per Share Data
EPS (TTM)$1.32
Forward EPS (Est.)$1.51
Book Value / Share$2.57
Revenue / Share$8.46
FCF / Share$0.95
Yields & Fair Value
Earnings Yield8.04%
Forward Earnings Yield9.63%
Dividend Yield0.00%
Graham Number$8.74
SharesGrow IV$59.70 (+281.7%)
Analyst Target$31.86 (+103.7%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
-516.5 |
0.00 |
0.00 |
144.41 |
- |
| 2017 |
-194.5 |
-1.15 |
-278.90 |
83.07 |
- |
| 2018 |
-133.5 |
-3.16 |
-89.69 |
55.58 |
- |
| 2019 |
-102.2 |
-3.15 |
38.82 |
29.39 |
- |
| 2020 |
-235.0 |
5.01 |
9.40 |
29.93 |
- |
| 2021 |
-162.8 |
-2.82 |
11.61 |
21.24 |
- |
| 2022 |
156.2 |
-1.05 |
5.70 |
7.67 |
- |
| 2023 |
554.1 |
-9.83 |
31.02 |
8.70 |
- |
| 2024 |
50.6 |
0.06 |
23.42 |
6.24 |
- |
| 2025 |
16.7 |
0.33 |
8.61 |
2.58 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-0.09 |
$9.85M |
$-2.75M |
-28% |
| 2017 |
$-0.24 |
$17.13M |
$-7.31M |
-42.7% |
| 2018 |
$-0.37 |
$27.07M |
$-11.27M |
-41.6% |
| 2019 |
$-0.49 |
$41.44M |
$-11.91M |
-28.7% |
| 2020 |
$-0.26 |
$62.92M |
$-7.65M |
-12.2% |
| 2021 |
$-0.41 |
$104.24M |
$-13.6M |
-13% |
| 2022 |
$0.20 |
$142.91M |
$7.02M |
4.9% |
| 2023 |
$0.08 |
$180.84M |
$2.84M |
1.6% |
| 2024 |
$0.86 |
$216.93M |
$26.74M |
12.3% |
| 2025 |
$1.30 |
$246.94M |
$38.17M |
15.5% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$1.50 |
$1.34 – $1.64 |
$262.46M |
$262.14M – $262.66M |
6 |
| 2027 |
$1.79 |
$1.61 – $2.01 |
$292.04M |
$289.37M – $294.94M |
5 |
| 2028 |
$2.34 |
$2.32 – $2.36 |
$321.17M |
$317.54M – $324.8M |
1 |
